GlassScriptPhysician profile
Martin Manansala
NPI 1962936526
$7,416.17
in general payments reported to CMS, 2019-2025
29 companies · $1,301 in 2025
The $1,301 reported for 2025 was more than what 90% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,268 · 2023: $3,385 · 2024: $1,463 · 2025: $1,301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,577 · Travel and Lodging: $1,571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,576.50 |
| Travel and Lodging | $1,571.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,579.16 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Abbvie INC. | $977.31 | 2022-2025 | |
| Boston Scientific Corporation | $394.04 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $345.12 | 2022-2024 | Senza |
| Collegium Pharmaceutical, INC. | $281.71 | 2022-2025 | Xtampza, Belbuca |
| Si-Bone, INC. | $222.40 | 2022-2023 | |
| Abbott Laboratories | $157.35 | 2023-2025 | Proclaim, Eterna |
| Pfizer INC. | $149.40 | 2023-2025 | |
| Averitas Pharma INC. | $140.07 | 2023-2025 | Qutenza |
| Biohaven Pharmaceutical Holding Company LTD. | $134.91 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $125.23 | 2023-2025 | Iovera, Zilretta |
| Spr Therapeutics, INC | $119.79 | 2023-2025 | Sprint Pns System |
| Foundation Fusion Solutions, LLC | $99.13 | 2023-2024 | |
| Spinal Simplicity, LLC | $86.60 | 2025 | Ha Minuteman G3-R |
| Merz Pharmaceuticals, LLC | $86.21 | 2022-2024 | Xeomin |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $82.48 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $79.07 | 2024-2025 | |
| Lilly USA, LLC | $51.93 | 2022-2024 | Emgality, Reyvow |
| Teva Pharmaceuticals USA, INC. | $50.49 | 2022-2024 | Ajovy |
| Vertos Medical, INC. | $48.91 | 2022-2024 | Mild Device Kit |
| Almatica Pharma LLC | $47.17 | 2022 | |
| Lundbeck LLC | $36.92 | 2022-2023 | Vyepti |
| Bioventus LLC | $29.47 | 2025 | Xcell |
| Ipsen Biopharmaceuticals, INC | $17.25 | 2025 | Dysport |
| Amneal Pharmaceuticals LLC | $16.73 | 2023 | Lyvispah |
| Avanos Medical | $14.89 | 2025 | |
| International Rehabilitative Sciences, INC | $14.82 | 2024 | Rs 4i Plus Sequential Stimulator |
| Azurity Pharmaceuticals, INC. | $14.65 | 2023 | Horizant |
| Fidia Pharma USA INC. | $12.96 | 2023 | Hymovis, Triluron |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Manansala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.